Screening for subclinical complications in young type 1 diabetic patients: experience acquired in Brussels

Harry Dorchy1

  • 1Clinique de Diabétologie, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Bruxelles, Belgium. hdorchy@ulb.ac.be

Insights

Screening for diabetic complications like retinopathy, neuropathy, and nephropathy should begin at puberty. Early detection and improved metabolic control can prevent irreversible lesions in children with diabetes.

Area of Science:

  • Pediatric diabetology
  • Clinical endocrinology
  • Diabetic complications research

Background:

  • Clinical studies since the 1970s highlight the need for early detection of diabetic complications.
  • Subclinical retinopathy, neuropathy, and nephropathy can be reversed with improved metabolic control.
  • Understanding risk factors and early markers is crucial for preventing long-term complications.

Purpose of the Study:

  • To establish optimal screening times for subclinical diabetic complications in children.
  • To identify early indicators of retinopathy, neuropathy, and nephropathy.
  • To investigate the relationship between metabolic control and the development of these complications.

Main Methods:

  • Longitudinal clinical studies and specific diagnostic tests including fluorescein angiography, EEG, nerve conduction studies, and biochemical markers.
  • Analysis of risk factors such as age at diagnosis, puberty, metabolic control, BMI, and cholesterol levels.
  • Evaluation of novel markers like microtransferrinuria, urinary acid glycosaminoglycans, and C-reactive protein.

Main Results:

  • Screening for retinopathy, neuropathy, and nephropathy should commence at puberty, at least 3 years post-diagnosis.
  • Early abnormalities like microaneurysms and nerve fiber desynchronization can precede overt lesions.
  • Risk factors identified include diabetes duration, younger age at diagnosis, puberty, poor metabolic control, high cholesterol, and elevated BMI.
  • Certain markers like microalbumin, Beta2-microglobulin, microtransferrinuria, and C-reactive protein show potential for early detection.

Conclusions:

  • Early detection of subclinical diabetic complications in children is feasible and essential.
  • Improved metabolic control is key to reversing early abnormalities and preventing irreversible damage.
  • Risk factor management and monitoring of specific biomarkers can aid in proactive intervention for diabetic microvascular and neurological complications.

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...